Company Overview

Drug Free Solution, Inc. (OTC: DSOL) is a publicly traded company that has historically been associated with workplace drug-testing, compliance, and substance-abuse prevention-related services in the United States. Public disclosures available through OTC Markets and archived corporate materials indicate that the company positioned itself around supporting employers, organizations, and institutional clients seeking drug-free workplace solutions and related compliance services. However, publicly available operational and financial information is limited, and the company has not maintained the same level of reporting transparency typically associated with fully reporting SEC registrants.

Based on available public records, the company appears to have operated primarily within the workplace compliance and health-services segment rather than as a diversified healthcare or pharmaceutical enterprise. Data regarding current revenue drivers, active product lines, and ongoing commercial scale is inconclusive based on available public sources. Historical materials suggest the company sought to differentiate itself through service-oriented compliance support tied to employer safety programs and testing administration.

Business Operations

Publicly available information indicates that Drug Free Solution, Inc. historically focused on drug-testing administration, workplace compliance support, and related service offerings tied to employee screening and organizational risk management. Detailed segment-level reporting, audited operational breakdowns, and current business-unit disclosures are not consistently available through recent public filings. As a result, precise revenue composition and operational scale cannot be independently verified from current public records.

The company appears to have operated primarily in the United States, with no broadly verified evidence of large-scale international operations, material foreign subsidiaries, or globally diversified business units. Information regarding proprietary technologies, major strategic partnerships, joint ventures, or controlled infrastructure assets remains limited. Data concerning active subsidiaries or operational affiliates is inconclusive based on available public sources.

Strategic Position & Investments

Historical company positioning suggests that Drug Free Solution, Inc. aimed to participate in the broader workplace safety and compliance sector through service-based offerings tied to employer drug-testing programs and regulatory compliance support. Publicly available disclosures do not provide sufficient evidence of large-scale acquisitions, institutional investments, or major expansion initiatives comparable to larger healthcare-services or diagnostics firms.

There is limited verifiable information regarding material investments in emerging technologies, digital health platforms, biotechnology, or advanced diagnostic systems. Likewise, no major portfolio companies or high-profile strategic acquisitions could be consistently confirmed through available public filings and market disclosures. Any assessment of current strategic direction should therefore be viewed cautiously due to limited reporting transparency.

Geographic Footprint

Available public information indicates that Drug Free Solution, Inc. maintained a primarily domestic operational focus within the United States. No substantial evidence from public disclosures confirms a significant operational presence across Europe, Asia-Pacific, Latin America, or other international regions.

The company’s publicly identifiable market activity has been associated mainly with U.S.-based workplace compliance and testing-related services. Information regarding foreign offices, cross-border investments, or multinational operating infrastructure is limited and could not be independently verified through widely available public records.

Leadership & Governance

Public information regarding the current leadership structure of Drug Free Solution, Inc. is limited and, in some cases, inconsistent across available market databases and historical disclosures. Due to the absence of comprehensive recent reporting and limited governance transparency, a fully verified executive roster could not be conclusively established from available public sources.

Known or historically referenced leadership information associated with the company includes:

• Data inconclusive based on available public sources � Current Chief Executive Officer
• Data inconclusive based on available public sources � Chief Financial Officer
• Data inconclusive based on available public sources � Board or executive leadership roles

Available materials suggest the company historically emphasized workplace compliance, risk mitigation, and employer-focused safety services as part of its operating philosophy. However, no recent, independently verifiable statements outlining a current long-term strategic vision or formal governance framework were consistently available through public disclosures.